[go: up one dir, main page]

AU6950294A - Treating body parts susceptible to ischemia using creatine analogs - Google Patents

Treating body parts susceptible to ischemia using creatine analogs

Info

Publication number
AU6950294A
AU6950294A AU69502/94A AU6950294A AU6950294A AU 6950294 A AU6950294 A AU 6950294A AU 69502/94 A AU69502/94 A AU 69502/94A AU 6950294 A AU6950294 A AU 6950294A AU 6950294 A AU6950294 A AU 6950294A
Authority
AU
Australia
Prior art keywords
ischemia
body parts
treating body
creatine analogs
parts susceptible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69502/94A
Inventor
Salwa A Elgebaly
Rima Kaddurah-Daouk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amira Inc
Hartford Hospital
Original Assignee
Amira Inc
Hartford Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amira Inc, Hartford Hospital filed Critical Amira Inc
Publication of AU6950294A publication Critical patent/AU6950294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU69502/94A 1993-05-14 1994-05-16 Treating body parts susceptible to ischemia using creatine analogs Abandoned AU6950294A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6167793A 1993-05-14 1993-05-14
US061677 1993-05-14
US24362894A 1994-05-16 1994-05-16
PCT/US1994/005425 WO1994026261A1 (en) 1993-05-14 1994-05-16 Treating body parts susceptible to ischemia using creatine analogs
US243628 2005-10-05

Publications (1)

Publication Number Publication Date
AU6950294A true AU6950294A (en) 1994-12-12

Family

ID=26741364

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69502/94A Abandoned AU6950294A (en) 1993-05-14 1994-05-16 Treating body parts susceptible to ischemia using creatine analogs

Country Status (2)

Country Link
AU (1) AU6950294A (en)
WO (1) WO1994026261A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859001A (en) 1996-01-11 1999-01-12 University Of Florida Research Foundation, Inc. Neuroprotective effects of polycyclic phenolic compounds
WO2007038341A2 (en) * 2005-09-23 2007-04-05 Nour Heart, Inc. Methods of organ protection
US11654134B2 (en) 2018-06-18 2023-05-23 Nour Heart, Inc. Cyclocreatine phosphate: a novel bioenergetic therapy to prevent and treat ischemia-induced and aging-related cardiovascular and neurodegenerative diseases
US11761966B2 (en) 2018-06-18 2023-09-19 Nour Heart, Inc. Nourin gene-based RNA molecular network: novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, STEMI/NSTEMI and heart failure
CA3162208A1 (en) * 2019-12-18 2021-06-24 Nour Heart, Inc. Cyclocreatine phosphate: a novel bioenergetic therapy to prevent and treat ischemia-induced and aging-related cardiovascular and neurodegenerative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843798A (en) * 1973-03-12 1974-10-22 Stanley Drug Products Inc Methods and compositions for inducing resistance to bacterial infections
IT1201511B (en) * 1985-12-23 1989-02-02 Italfarmaco Spa CITOPROTECTIVE DERIVATIVES IN ISCHEMIC-BASED DISEASES, THEIR PREPARATION AND COMPOSITIONS THAT CONTAIN THEM
US5190976A (en) * 1986-07-10 1993-03-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And University Of Oregon N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists
IT1237519B (en) * 1989-11-27 1993-06-08 USE OF GUANIDINACETIC ACID TO INDUCE AN INCREASE IN THE CREATINE MUSCLE CONTENT
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
US5091404A (en) * 1990-10-05 1992-02-25 Elgebaly Salwa A Method for restoring functionality in muscle tissue
US5290766A (en) * 1991-02-18 1994-03-01 The National Heart Foundation Of New Zealand Cardioplegic compositions

Also Published As

Publication number Publication date
WO1994026261A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
AU5021693A (en) Acyl lactylates as skin elasticity enhancing agents
AU6597898A (en) Creatine analogs having antiviral activity
PL313787A1 (en) Polycycloalkanes as dichelant compounds
ZA949050B (en) Cyclic amino acid derivatives
GB9317967D0 (en) Improvements relating to plasics articles
GB9310445D0 (en) Improvements to pyrotechnic tensioning devices
AU6950294A (en) Treating body parts susceptible to ischemia using creatine analogs
GB9418205D0 (en) Improvements relating to strimmers
AU6575894A (en) Body massager
GB2263726B (en) Cam cleats
GB2272770B (en) Improvements to electrocardiagraphs
GB9411992D0 (en) Preparation for epidermis
AU6097994A (en) Creatine phosphate, creatine phosphate analogs, and uses therefor
GB2279435B (en) Improvements relating to trackerballs
GB9305870D0 (en) Improvements relating to locks
GB2276681B (en) Improvements relating to sealing arrangements
AU6060594A (en) Improvements to vehicles
GB2275466B (en) Improvements relating to containers
GB2280658B (en) Improvements relating to containers
AU3211093A (en) Cam cleats
AU7947994A (en) Improvement to electromagnetotherapy apparatuses
GB9309898D0 (en) Improvements relating to hoisiery
GB9303708D0 (en) Improvements relating to locks
GB9309899D0 (en) Improvements to guns
AU3664089A (en) Cam cleat